Intrapleural use of tissue plasminogen activator and DNase in pleural infection

Intrapleural use of tissue plasminogen activator and DNase in pleural infection

Mostrar otras versiones (1)

BACKGROUND: More than 30% of patients with pleural infection either die or require surgery. Drainage of infected fluid is key to successful treatment, but intrapleural fibrinolytic therapy did not improve outcomes in an earlier, large, randomized trial. METHODS: We conducted a blinded, 2-by-2 factor...

Descripción completa

Detalles Bibliográficos
Autores principales: Rahman, N, Maskell, N, West, A, Teoh, R, Arnold, A, Mackinlay, C, Peckham, D, Davies, C, Ali, N, Kinnear, W, Bentley, A, Kahan, B, Wrightson, J, Davies, H, Hooper, C, Lee, Y, Hedley, E, Crosthwaite, N, Choo, L, Helm, E, Gleeson, F, Nunn, A, Davies, R
Formato: Journal article
Lenguaje:English
Publicado: 2011

Ejemplares similares

Ejemplares similares